G1 Therapeutics Inc (GTHX)
$0.00 $0.00 (0.00%) 12:08 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$377.22M -
Day's Range
- - - -
Volume
1,618,732 -
52 Week Low / High
$1.44 - $7.19 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
GTHX's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 1
- Strong Buy
- 0
- Buy
- 4
- Hold
- 0
- Sell
- 0
- Strong Sell
- $9.50
- Target Price
Company News
-
G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference — Jan 8th, 2024
G1 Therapeutics - Initial Data from the Ongoing Phase 2 Trial in Combination with the Antibody-Drug Conjugate (ADC) Sacituzumab Govitecan (SG) Suggest a Potentially Meaningful Improvement in Overall Survival (OS) for Patients Receiving Trilaciclib - - COSELA® (trilaciclib) Vial Volume G...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$